Danegaptide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Danegaptide, covering 2018-04-06 to 2018-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Clinical Proof-of-Concept Study of the Cardioprotective Properties of Danegaptide in ST Segment Elevation Myocardial Infarction [Phase 2]